Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Learn what is the most efficient way to save money through expert insights. Implement these strategies for better savings.
22,243 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
AI excitement is lifting chipmakers, and Arm is leading the charge. This piece explains why holdings stock jumped hig...
Industry watchers say Brookfield Infrastructure could quietly leverage a wave of rail asset divestitures tied to the ...
A hedge fund made a sizable Ultragenyx purchase as the stock slipped about 30% over the prior year. This article brea...
ICE launches an Encompass-integrated Fraud Monitor, centralizing fraud risk signals and property data. Early pilots i...
With the trust fund projected to deplete in the coming years, benefit payments could fall short unless Congress acts....
Dell stock is on a rapid uptrend as profits beat expectations. This guide breaks down whether the rally can continue ...
As crude rises, bitcoin sinks to fresh multi-month lows. This article unpacks the connection between oil and crypto, ...
Premu launches a new feature that lets anyone create World Cup markets with up to 2.5x leverage and collect trading f...
Zcash plunged about 45% after the founder disclosed a vulnerability in the Orchard shielded pool. The flaw, if exploi...
Planet Labs stock plummeting has investors weighing quarterly results against space-tech hype. This guide breaks down...
A six-month surge in Asia’s 50 largest stocks turned a $10,000 stake into $15,267 by early June 2026, outperforming t...